Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Methylation Signature at the Cpg Island Promoter of Estrogen Receptor Beta (Er-Β) in Breasts of Women May Be an Early Footmark of Lack of Breastfeeding and Nulliparity Publisher Pubmed



Daraei A1 ; Izadi P2 ; Khorasani G3 ; Nafissi N4 ; Naghizadeh MM5 ; Meysamie A6 ; Mansoori Y5 ; Narimansalehfam Z7 ; Bastami M5 ; Saadatian Z8 ; Roshan SJ1 ; Bayani N9 ; Tavakkolybazzaz J2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Genetics, School of Medicine, Babol University of Medical Sciences, Babol, Iran
  2. 2. Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Division of Plastic and Reconstructive Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Surgical Department, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
  6. 6. Community and Preventive Medicine Department, Medical Faculty, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  8. 8. Department of Physiology, Faculty of Medicine, Gonabad University of Medical Sciences, Gonabad, Iran
  9. 9. Department of Biology, Faculty of Sciences, Arak University, Arak, Iran

Source: Pathology Research and Practice Published:2021


Abstract

Although little is known regarding the mechanisms behind the onset of breast cancer (BC) through reproductive risk factors, new researches have highlighted some early tumor-related methylation footmarks in the breast tissue of apparently clinically healthy women as their potential epigenetic mechanism. Previous evidence supports that the estrogen receptor beta (ER-β), whose anti-cancer roles had already been revealed in BC, is downregulated in the breasts of healthy nulliparous women. Nevertheless, data on such a link about its methylation alterations have not been reported. The goal of current study was to determine possible methylation alterations at CpG island promoter of the ER-β gene, including promoter 0 N and exon 0 N, in relation to aspects of reproductive history in the healthy breasts. The DNA was extracted from the breasts of 120 subjects undergoing cosmetic mammoplasty. Thereafter, the methylation levels of targeted regions in ER-β gene were determined by using MeDIP-qPCR assay. The results revealed that ER-β exon 0 N had no methylation in 84.2 % of the women, whereas the rest, comprising 2.5 % and 13.3 % of the samples, showed a lower and higher of its methylation, respectively. Interestingly, nulliparous women were found to have an elevated methylation level of the ER-β exon 0 N than parous women (P = 0.036). Moreover, we observed a high methylation of the ER-β exon 0 N in the breasts of non-breastfeeding women compared to breastfeeding subgroup (P = 0.048). Likewise, the non-breastfeeding subgroup showed exon 0N high methylation in comparison to women with breastfeeding >24 months (P = 0.023). Finally, although we found that 6.67 % of the samples had a high methylation level at the promoter 0N, no any relationship was found between its methylation and reproductive history. These results may provide key clues to revealing the epigenetic mechanism through which the nulliparity and lack of breastfeeding influencing the risk factor of BC as well as introducing the potential new early prediction and prevention strategies. Although further investigations need to be done in order to gain a better understanding the roles of these epigenetic signatures. © 2020 Elsevier GmbH